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Previous studies suggest that high parity increases the risk of cervical cancer. We studied the risk of cervical cancer (CC) and cervical
intraepithelial neoplasia (CIN3) in a Finnish cohort of grand multiparous (GM) women (at least five children) with low prevalence of
sexually transmitted infections (STI). The Finnish Cancer Registry data revealed 220 CC and 178 CIN3 cases among 86978 GM
women. Standardised incidence ratios (SIR) were calculated from the numbers of observed and expected cases. Interval analyses by
parity, age at first birth and average birth interval were done using multivariate Poisson regression. Seroprevalence of human
papillomavirus (HPV) 16 and Chlamydia trachomatis was tested among 561 GM women and 5703 women with 2–4 pregnancies. The
incidence among GM women was slightly above the national average for squamous cell carcinoma of cervix uteri (SIR 1.21, 95% CI
1.05–1.40) and CIN3 (1.37, 95% CI 1.17–1.58), but lower for adenocarcinoma (SIR 0.77, 95% CI 0.52–1.10). The seroprevalence of
HPV16 and Chlamydia trachomatis among GM women was lower than in the reference population, except among those women who
had their child under age 19. Age under 20 years at first birth increased the risk of CC and CIN3 especially in premenopausal GM
women, while increasing parity had no effect. The small relative risks of CC and CIN3 among GM women in our study as compared
to studies from other countries can be explained by the exceptionally low prevalence of STIs in Finnish GM women. The observed
SIRs between 1.2 and 1.4 should be interpreted to represent increased risk attributable to grand multiparity. The increased incidence
of CC and CIN3 among young GM women suggests causal association to HPV 16 and Chlamydia trachomatis infections.
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Multiparity is believed to be a risk factor for cervical cancer (CC),
especially among human papilloma virus (HPV)-positive women
(Eluf-Neto et al, 1994). The relative risk (RR) of CC among women
with five or more births varied from 3.8 (in squamous cell
carcinoma) (Munoz et al, 2002) to 4.4 (Parazzini et al, 1989) in
recent studies, compared with nulliparous, or 5.1 compared with
nulliparous or primiparous women (Brinton et al, 1989).
Human papillomavirus, most notably types HPV16 and 18
(Munoz et al, 1994; Lehtinen et al, 1996; Dillner et al, 1997;
Walboomers et al, 1999; Wallin et al, 1999) and Chlamydia
trachomatis infections (Koskela et al, 2000; Anttila et al, 2001) have
an important role in the aetiology of CC. Postulated risk factors for
CC include, for example, use of oral contraceptives and smoking
(La Vecchia et al, 1986; Brinton et al, 1987b; Schiffman and
Brinton, 1995; Schiffman et al, 1996; Hakama et al, 2000).
We studied the significance of multiparity in the aetiology of
cervical cancer of Finnish grand multiparous (GM) women with at
least five biological children (Solomons, 1934). Most of the GM
women belong to the religious movement of Laestadius within the
Lutheran church. High parity is common within this movement, as
any kind of contraception is forbidden. Other life habits of the
members in this group do not markedly differ from the ordinary
Finns. Smoking is permitted, but alcohol consumption is unusual.
Since extramarital sexual contacts are unacceptable and rare in this
movement, the risk of HPV and Chlamydia trachomatis infections
of Finnish GM women is presumably low.
MATERIAL AND METHODS
The computerised files of the Finnish Population Register revealed
86978 women with at least five children until the end of 1997. The
files include links between parents and their children living at the
same address in 1974 or later. Follow-up for CC and CIN was done
automatically through the files of the national population-based
Finnish Cancer Registry with personal identifiers as the key.
The cancer registry data also included information about clinical
stage and histopathological diagnosis. The CIN group includes
patients with histological diagnosis of carcinoma in situ or severe
dysplasia in the old classification, or CIN grade 3 in the new
classification.
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Health Institute has collected and stored (at  251C) first trimester
serum samples from all (98%) pregnant women in Finland
since 1983. Seroprevalences of HPV16 and Chlamydia trachomatis
were analysed in a stratified random sample of 6264 women
with two pregnancies in FMC with standard ELISA methods
(Laukkanen et al, 2003). These women were linked with the
GM cohort. The FMC comprised 561 GM women, whose HPV16
and Chlamydia trachomatis seroprevalence was compared with
that of women of the same age and period in the rest of sample
(n¼5703).
STATISTICAL METHODS
The follow-up started from the birth of the fifth child or first of
January 1974, whichever was later and ended at emigration, death
or 31 of December 1997, whichever overcame first. The number of
person years was 1.68 million.
The numbers of observed cases of CC and CIN3 and person-
years at risk were counted by 5-year age groups and separately for
four parity categories (5, 6, 7 and 8þ children), four categories by
the age at first birth (o20, 20–24, 25–29 and 30þ years) and
three birth interval categories according to the average interval
between the first five deliveries (o2.0, 2.0–3.0 and 43.0 years).
Age at follow-up of cancer was categorised into four groups (o40,
40–49, 50–64 and 65þ years).
The expected numbers of cases were calculated by multi-
plying the number of person-years in each stratum by the
corresponding incidence rate in Finland. The standardised
incidence ratio (SIR) was calculated by dividing the number of
observed cases by the number of expected cases. The 95%
confidence intervals (95% CI) for the SIRs were based on the
assumption that the number of observed cases presents a Poisson
distribution.
Poisson regression modelling of the stratum-specific observed
and expected number was used to assess the effects (RR) of all
relevant variables simultaneously. The analyses were performed
using the SAS statistical software (1997).
RESULTS
GM women had 220 CC and 178 CIN3 cases, only slightly more
than expected (CC; SIR 1.13, 95% CI 0.98–1.29) (CIN3; SIR 1.37,
95% CI 1.17–1.58). The SIR of both CC and CIN3 was smallest
among women with at least eight children (Table 1). The younger
the age at first birth, the greater was the SIR of CC and CIN3.
The SIR of CIN3 was significantly above the national average
in women with the average birth interval under 3 years. The
excess in incidence of CC was only seen in cancer diagnosed in
women under 50 years of age (SIR 1.56, 95% CI 1.18–2.02), 26%
of cases.
In all, 190 cases had squamous-cell carcinoma (SCC) (86%) and
30 cases had adenocarsinoma (14%). The incidence of SCC was
above (SIR 1.21, 95% CI 1.05–1.40) and that of adenocarcinoma
slightly below (SIR 0.77, 95% CI 0.52–1.10) the national average.
Increasing parity and long birth interval seemed to decrease the
SIR of adenocarsinoma (SIR for 8þ birth, 0.22 and 95% CI 0.01–
1.20; SIR for birth interval 43.0 year, 0.41 and 95% CI 0.13–0.95),
but the number of cases was small for proper evaluations.
The disease represented clinical (according to Finnish Cancer
registry) stage I in 57%, stage II in 11% and stage III in 32% of the
195 cases with a known stage. The Stage II cases had increased SIR
(SIR 1.74, 95% CI 1.09–2.64), but in other stages SIRs were about
the same as SIR for CC (Stage I, SIR 1.17 and 95% CI 0.97–1.41;
Stage III, SIR 1.08 and 95% CI 0.83–1.39).
According to multivariate analysis, the RR for CC in ages under
40 years was 2.30-fold (95% CI 1.27–4.16) compared with cases
above 65 years of age, if the reproductive factors were the same
(Table 2). Young age at first birth was associated with increased
risk of both CC and CIN3. This phenomenon in CC (Table 3) or
CIN3 (Table 3) was, however, significant only among GM women
under 50 years of age. In postmenopausal GM women, an
increased CIN3 risk was associated with short birth interval
(Table 3).
The seroprevalence of HPV16 and Chlamydia trachomatis
among the 561 GM women included into the FMC sample of
6264 women were 10 and 11%, respectively, which was about half
of that in the rest of the sample (Figure 1). GM women under 19
Table 1 Observed (Obs) and expected (Exp) number of cervical intraepithelial neoplasia (CIN3) and cervical cancer (CC) cases and standardised
incidence ratios (SIR¼Obs/Exp), with 95% confidence intervals (95% CI), among women with at least five children
CIN3 CC
Variable Obs Exp SIR 95% CI Obs Exp SIR 95% CI
Parity
5 92 70 1.32 1.06–1.62 111 98 1.13 0.93–1.36
6 52 34 1.55 1.16–2.03 65 56 1.17 0.90–1.49
7 18 12 1.48 0.88–2.34 24 18 1.32 0.84–1.96
8+ 16 15 1.08 0.62–1.76 20 23 0.87 0.53–1.34
Age at first birth (years)
o20 51 29 1.74 1.30–2.29 42 23 1.82 1.31–2.46
20–24 93 71 1.31 1.06–1.61 107 94 1.14 0.94–1.38
25–29 27 25 1.09 0.72–1.58 54 59 0.92 0.69–1.20
30+ 7 5 1.33 0.53–2.73 17 20 0.87 0.51–1.39
Birth interval (years)
o2.0 68 42 1.62 1.26–2.05 68 55 1.24 0.97–1.58
2.0–3.0 72 50 1.45 1.13–1.82 78 79 0.99 0.78–1.24
3.0+ 38 38 0.99 0.70–1.36 74 62 1.20 0.94–1.50
Age at follow up (years)
o40 38 25 1.51 1.07–2.08 17 7 2.36 1.37–3.77
40–49 62 44 1.42 1.09–1.82 40 29 1.36 0.97–1.86
50–64 59 48 1.23 0.94–1.5 106 100 1.07 0.87–1.29
65+ 19 14 1.41 0.85–2.20 57 59 0.96 0.73–1.25
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trachomatis seroprevalences (27% and 16%).
DISCUSSION
We studied the widely accepted hypothesis that multiparity is
associated with increased risk for CC and CIN in a national cohort
of GM women in Finland. The national population-based
databanks of the Finnish Population Register and the Finnish
Cancer Registry are virtually complete and the computerised
record linkage using personal identifiers as a key is precise.
In this study, the incidence of CC and CIN3 among GM women
was slightly higher than that among average female population. In
Italy, the RR for CC for 5-paras was 4.4 compared with nulliparous
women (Parazzini et al, 1989). In the Multicentric IARC study with
low- and high-risk countries for 7-paras, the RR of SCC was 3.8
compared with nulliparas and 2.3 compared with women with one
or two full-term pregnancies (Munoz et al, 2002). In the Latin
American countries, the RR was 5.1 for 14þ-paras compared with
Table 2 Relative risks (RR) with 95% confidence intervals (95% CI) for
cervical intraepithelial neoplasia (CIN3) and cervical cancer (CC) among
women with at least five children, by study variables, adjusted for each
other
CIN3 CC
Variable RR 95% CI RR 95% CI
Parity
5 1.00 Ref 1.00 Ref
6 1.03 0.72–1.47 1.08 0.78–1.48
7 0.90 0.54–1.53 1.14 0.72–1.82
8+ 0.63 0.36–1.11 0.73 0.44–1.21
Age at first birth (years)
o20 1.00 Ref
a 1.00 Ref
20–24 0.72 0.51–1.02 0.73 0.51–1.06
25–29 0.54 0.33–0.90 0.66 0.42–1.03
30+ 0.57 0.24–1.33 0.65 0.35–1.23
Birth interval (years)
o2.0 1.00 Ref
b 1.00 Ref
2.0–3.0 0.81 0.58–1.15 0.79 0.57–1.11
3.0+ 0.52 0.34–0.81 0.91 0.63–1.33
Age at follow up (years)
o40 0.73 0.39–1.37 2.30 1.27–4.18
c
40–49 0.74 0.40–1.37 1.55 0.95–2.52
50–64 0.74 0.42–1.29 1.25 0.87–1.81
65+ 1.00 Ref 1.00 Ref
aTrend P¼0.02.
bTrend P¼0.004.
cTrend P¼0.0003.
Table 3 Observed number of cervical cancer (CC) cases (Obs) and cervical intraepithelial neoplasia (CIN3) and model-based relative risks (RR)
according to study variables with 95% confidence intervals (CI 95%) among GM women, by age at diagnosis
CC CIN3
Age at diagnosis o 50 years Age at diagnosis 50+ Age at diagnosis o50 years Age at diagnosis 50+
Variable Obs RR 95% CI Obs RR 95% CI Obs RR 95% CI Obs RR 95% CI
Parity
5 31 1.00 Ref 80 1.00 Ref 55 1.00 Ref 37 1.00 Ref
6 11 0.76 0.37–1.53 54 1.15 0.80–1.64 24 0.97 0.59–1.59 28 1.11 0.67–1.83
7 4 0.68 0.23–1.98 20 1.30 0.78–2.18 12 1.21 0.63–2.31 60 0.62 0.26–1.52
8+ 11 1.54 0.70–3.37 9 0.44 0.22–0.91 9 0.80 0.38–1.70 7 0.53 0.23–1.24
Age at first birth (years)
o 20 24 1.00 Ref
a 18 1.00 Ref 42 1.00 Ref
b 9 1.00 Ref
20–24 30 0.62 0.36–1.06 77 0.78 0.46–1.30 52 0.68 0.45–1.02 41 1.01 0.49–2.08
25+ 3 0.25 0.07–0.83 68 0.71 0.42–1.21 6 0.35 0.15–0.83 28 0.93 0.43–2.02
Birth interval (years)
o 2.0 21 1.00 Ref 47 1.00 Ref 36 1.00 Ref 32 1.00 Ref
c
2.0–3.0 22 0.99 0.52–1.88 56 0.73 0.49–1.08 43 1.09 0.68–1.73 29 0.58 0.34–0.96
3.0+ 14 0.67 0.31–1.47 60 0.97 0.64–1.48 21 0.67 0.37–1.20 17 0.41 0.22–0.78
aTrend P¼0.01.
bTrend P¼0.005.
cTrend P¼0.005.
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Figure 1 Prevalence of HPV16 (K) and Chlamydia trachomatis (J)
among GM women (solid line, —), and women with 2–4 pregnancies
(dotted lines, ---), in 1983–1993, by age at pregnancy.
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younger than 45 years with three or more births had an increased
risk of 8.1 compared with nulliparous women, and the RR
increased with the number of births (Parazzini et al, 1998). All
these RR estimates are clearly higher than the RR of 1.13 seen in
our study. In addition, GM women did not show any trend towards
increasing risk of CC or CIN3, with rising number of births from 5
to 8þ. The risk estimate was actually lowest in women with 8þ
births. Anyway, as our reference group was the entire population
with the mean number of 1.5–1.7 births per woman during the
study period (www.stat.fi), the RR estimates might have been
larger, when compared to nulliparous women.
There are also studies which do not show any role for
multiparity in the aetiology of CC or CIN (Rotkin, 1973; Kvale
et al, 1988; Cuzick et al, 1996). In those studies, crude RRs of CC
were 0.6–2.3 for women with five or more pregnancies. However,
after adjustment for the age at first birth the RR dropped close to
1.0. Similar RRs for CIN have been found in several studies
adjusted for age at first birth or number of sexual partners
(Parazzini et al, 1989, 1992; Jones et al, 1990).
The incidence of CC in Finland is low due to the nationwide
organised Pap smear screening programmes, conducted since 1965
with 5-year interval among women over 30 years of age (Hakama,
1985). Maternal health care with several pelvic examinations
during pregnancy and puerperium (including Pap smears) has
been free of charge for over 40 years in Finland with 98%
participation rate. These national programmes have promoted the
early detection and treatment of CINs, and thus decreased CC
incidence in Finnish women. It seems unlikely that these public
health programmes have reduced the CC differently in GM women
than in the rest of the population. The Pap smear screening and
maternal health-care programmes are unlikely to bias our RR
estimates. However, these programmes have changed the stage and
histology distribution of CC in Finland. The fraction of slow-
growing cancers has strongly decreased. Screening also reduces
mainly SCC, and therefore the relative proportion of adenocarci-
noma increases (Anttila et al, 1999). The effect of parity is also
dissimilar to different stages or histologies, and this can make it
difficult to compare RRs observed in Finland and other countries.
Reproductive factors affect the pathogenesis of SCC and
adenocarcinoma in different ways (Munoz et al, 2002). The
incidence of cervical adenocarcinoma among Finnish GM women
was low, a finding that resembles the results of our previous
studies on adenocarcinoma of the breast (Hinkula et al, 2001) and
endometrium (Hinkula et al, 2002). Cervical adenocarcinoma may
resemble endometrial adenocarcinoma, as regards aetiological
association with nulliparity and obesity (Schiffman et al, 1996).
According to the study by Brinton et al (1993), the cervical
adenocarcinoma appeared to be less affected by sexual and
reproductive factors, whereas in study by Italian, the RR of
adenocarcinoma increased with the number of births (Parazzini
et al, 1988). The epidemiology of cervical adenocarcinoma is still
poorly understood (Korhonen, 1980).
There are several pregnancy-induced cervical changes, which
may predispose to malignant transformation. Multiparity may
increase the risk of CC by maintaining the transformation zone on
the ectocervical region. Moreover, the number of squamous
metaplastic cells in the transformation zone increases during
pregnancy (Munoz et al, 2002). In their immature phase of
development, the metaplastic cells are most susceptible to HPV
infection and possibly later to progression to CC. The metaplastic
transformation zone in the ectocervix of a GM woman will
repeatedly be exposed to carcinogenetic agents. For this reason,
multiparity may intensify the actions of carcinogenic infectious
agents (Nair and Pillai, 1992).
Our data did not include any information about the age at first
intercourse, smoking or Caesarean sections also thought to be
involved in the pathogenesis of CC (Bosch et al, 1992; Munoz et al,
2002). The GM women are, however, believed to be similar to the
average Finnish women with respect to the most general life style
factors or manner of delivery. However, in contrast to the
reference population, most GM women restrain from using any
kind of contraception for religious reasons. Our assumption of the
low risk of STIs of the Finnish GM women proved to be true based
on the low seropositivity rates to HPV and Chlamydia trachomatis,
except among those who had children at an average age of less
than 19 years. Both of those features are characteristic of our
cohort partly for religion reason. There are also other studies with
low CC risks in different religious groups as Catholic nuns, the
Amish, Mormons and Jews, probably because of a smaller number
of sexual partners and lowered infection risk (Schiffman et al,
1996).
Infections with oncogenic HPV types are the main causes of CC
(Eluf-Neto et al, 1994). The pooled data from eight studies
indicated that high parity increases the risk of SCC only in HPV-
positive women (Munoz et al, 2002). There are also conflicting
results. Parity may be risk factor of CC rather among HPV-
negative than HPV-positive women (Brinton et al, 1989). Despite
the low prevalence of HPV16- and Chlamydia trachomatis-positive
women in our cohort compared to the reference population,
the SIRs of CC and CIN3 were increased. This finding indicates
that multiparity per se played a role in the aetiology of these
diseases.
GM women who had their first child at young age were an
exception to the general tendency; they had a high prevalence of
HPV16 and Chlamydia trachomatis compared to other age groups
and a similar or a slightly higher prevalence than in reference
women of the same age. They had an increased risk of CC and
CIN3, especially in premenopausal ages. This finding agrees with
the results of some (Brinton et al, 1987a; Cuzick et al, 1990; Bosch
et al, 1992; La Vecchia et al, 1993), but not all previous studies
(Parazzini et al, 1989, 1998; Munoz et al, 1993; Mukherjee et al,
1994; Autier et al, 1996; Munoz et al, 2002).
The importance of age at first birth has been shown to disappear
after inclusion parity (Parazzini et al, 1989) or the age at first
marriage, education and parity (Mukherjee et al, 1994) in multiple
logistic regression analysis. Theoretically, young age at first birth
could be an independent risk factor for CC, because the cervix is
most vulnerable at young age, when the risk of sexually
transmitted diseases is most prominent. The degree of nuclear
atypia increases with the duration of infection (Nair and Pillai,
1992; Schiffman et al, 1996).
Short interval between births was associated with an increased
risk of CIN3 in postmenopausal GM women. The maintenance of
the transformation zone on the ectocervix for a prolonged time
increases its susceptibility to the external agents involved in
dysplastic lesions (Autier et al, 1996). In contrast to a study from
India (Mukherjee et al, 1994), where birth interval had an
independent effect on risk increase of CC, our study, as in a
majority of other studies (Munoz et al, 2002), failed to reveal such
an association for CC.
In conclusion, although the seroprevalence of HPV16 and
Chlamydia trachomatis in Finnish GM women was small, the
incidence of CC and CIN3 was slightly but significantly above the
national average. Multiparity seems thus to be an independent risk
factor of CC also in a country with effective national programmes
for an early detection and treatment of CINs. Young age at first
birth also plays a significant role in the aetiology of CC and CIN3,
probably in association with STIs.
ACKNOWLEDGEMENTS
This work was supported by grants from the Cancer Society of
Finland, Finnish Obstetrical and Gynaecological Research Founda-
tion and Orion Pharma Research Foundation.
Grand multiparity and cervical cancer
M Hinkula et al
1028
British Journal of Cancer (2004) 90(5), 1025–1029 & 2004 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yREFERENCES
Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M (1999)
Effect of organised screening on cervical cancer incidence and mortality
in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J
Cancer 83: 59–65
Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E,
Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S,
Youngman L, Paavonen J (2001) Serotypes of Chlamydia trachomatis
and risk for development of cervical squamous cell carcinoma. JAMA
285: 47–51
Autier PCM, Huet F, Grivegnee AR (1996) Transformation zone location
and intraepithelial neoplasia of the cervix uteri. Br J Cancer 74: 488–490
Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo
MJ, Moreo P, Ascunce N, Gonzalez LC, Tadar L, Kaldo JM, Guerrero F,
Aristizabal N, Santamaria M, Alonso de Ruiz P, Shah K (1992) Risk
factors for cervical cancer in Colombia and Spain. Int J Cancer 52: 750–
758
Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K,
Fraumeni Jr JF (1987a) Sexual and reproductive risk factors for invasive
squamous cell cervical cancer. J Natl Cancer Inst 79: 23–30
Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F
(1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51:
301–306
Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E,
Tenorio F, Garcia M, Rawls WE (1989) Parity as a risk factor for cervical
cancer. Am J Epidemiol 130: 486–496
Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA,
Stolley PD, Fraumeni Jr JF (1987b) Epidemiology of cervical cancer by
cell type. Cancer Res 47: 1706–1711
Cuzick J, Sasieni P, Singer A (1996) Risk factors for invasive cervix cancer
in young women. Eur J Cancer 32A: 836–841
Cuzick J, Singer A, De Stavola BL, Chomet J (1990) Case–control study of
risk factors for cervical intraepithelial neoplasia in young women. Eur J
Cancer 26: 684–690
Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E,
Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT,
Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemio-
logic study of human papillomavirus infection as a risk factor for
invasive cervical cancer. J Natl Cancer Inst 89: 1293–1299
Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM
(1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J
Cancer 69: 114–119
Hakama M (1985) Effect of population screening for carcinoma of the
uterine cervix in Finland. Maturitas 7: 3–10
Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M,
Thoresen S, Youngman L, Hakulinen T (2000) Joint effect of HPV16 with
Chlamydia trachomatis and smoking on risk of cervical cancer:
antagonism or misclassification (Nordic countries). Cancer Causes
Control 11: 783–790
Hinkula M, Pukkala E, Kyyro ¨nen O, Kauppila A (2001) Grand multiparity
and risk of breast cancer; population-based study in Finland. Cancer
Causes Control 12: 491–500
Hinkula M, Pukkala E, Kyyro ¨nen P, Kauppila A (2002) Grand multiparity
and incidence of endometrial cancer: a population-based study in
Finland. Int J Cancer 98: 912–915
Jones CJ, Brinton LA, Hamman RF, Stolley PD, Lehman HF, Levine RS,
Mallin K (1990) Risk factors for in situ cervical cancer: results from a
case–control study. Cancer Res 50: 3657–3662
Korhonen MO (1980) Epidemiological differences between adenocarcino-
ma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 10:
312–317
Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen
T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P,
Thoresen S, Youngman L, Paavonen J (2000) Chlamydia trachomatis
infection as a risk factor for invasive cervical cancer. Int J Cancer 85:
35–39
Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical
cancer by cell type. A prospective study. Br J Cancer 58: 820–824
La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G
(1986) Cigarette smoking and the risk of cervical neoplasia. Am J
Epidemiol 123: 22–29
La Vecchia C, Negri E, Franceschi S, Parazzini F (1993) Long-term impact
of reproductive factors on cancer risk. Int J Cancer 53: 215–219
Laukkanen P, Koskela P, Pukkala E, Dillner J, La ¨a ¨ra ¨ E, Knekt P,
Lehtinen M (2003) Time trends in incidence and prevalence of human
papillomavirus type 6,11 and 16 prevalence in Finland. J Gen Virol 84:
2105–2109
Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R,
Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M (1996)
Serologically diagnosed infection with human papillomavirus type 16
and risk for subsequent development of cervical carcinoma: nested
case–control study. Br Med J 312: 537–539
Mukherjee BN, Sengupta S, Chaudhuri S, Biswas LN, Maiti P (1994) A
case–control study of reproductive risk factors associated with cervical
cancer. Int J Cancer 59: 476–482
Munoz N, Bosch FX, de Sanjose S, Shah KV (1994) The role of HPV in the
etiology of cervical cancer. Mutat Res 305: 293–301
Munoz N, Bosch FX, de Sanjose S, Vergara A, del Moral A,
Munoz MT, Tafur L, Gili M, Izarzugaza I, Viladiu P, Navarro C, Alanso
de Ruiz P, Anstizabal N, Santamaria M, Ordila J, Daniel RW, Guerrero E,
Shah K (1993) Risk factors for cervical intraepithelial neoplasia grade III/
carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers
Prev 2: 423–431
Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah
KV, Meijer CJ, Bosch FX, International Agency for Research on
CancerMulticentric Cervical Cancer Study G (2002) Role of parity and
human papillomavirus in cervical cancer: the IARC multicentric case–
control study. Lancet 359: 1093–1101
Nair BS, Pillai R (1992) Oncogenesis of squamous carcinoma of the uterine
cervix. Int J Gynecol Pathol 11: 47–57
Parazzini F, Chatenoud L, La Vecchia C, Negri E, Franceschi S, Bolis G
(1998) Determinants of risk of invasive cervical cancer in young women.
Br J Cancer 77: 838–841
Parazzini F, La Vecchia C, Negri E, Cecchetti G, Fedele L (1989)
Reproductive factors and the risk of invasive and intraepithelial cervical
neoplasia. Br J Cancer 59: 805–809
Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors
for adenocarcinoma of the cervix: a case–control study. Br J Cancer 57:
201–204
Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L
(1992) Risk factors for cervical intraepithelial neoplasia. Cancer 69:
2276–2282
Rotkin ID (1973) A comparison review of key epidemiological studies in
cervical cancer related to current searches for transmissible agents.
Cancer Res 33: 1353–1367
Schiffman M, Brinton LA, Devesa SS, Fraumeni Jr JF (1996) Cervical cancer.
Cancer Epidemiology and Prevention, 2nd edn. pp 1090–1116. Oxford:
Oxford University Press
Schiffman MH, Brinton LA (1995) The epidemiology of cervical
carcinogenesis. Cancer 76: 1888–1901
Solomons B (1934) The dangerous multipara. Lancet 2: 8–11
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV,
Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is
a necessary cause of invasive cervical cancer worldwide. J Pathol 189:
12–19
Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G,
Hallmans G, Dillner J (1999) Type-specific persistence of human
papillomavirus DNA before the development of invasive cervical cancer.
N Engl J Med 341: 1633–1638
www.stat.fi. (2001) Statistics Finland, Helsinki
Grand multiparity and cervical cancer
M Hinkula et al
1029
British Journal of Cancer (2004) 90(5), 1025–1029 & 2004 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
y